Pharma & Biotech
Proactive spoke to three firms that delivered positive results this quarter about their thoughts on what...
14.40 Wed 23 Sep 2020
Champignon Brands is making a scientific case for psychedelic medicine
Genprex gene therapy candidate Oncoprex fast-tracking for non-small cell lung cancer treatment
Antibe Therapeutics is ready for a big push as it progresses pain management drug through clinical trials
Only registered members can use this feature.
Copyright © Proactive Investors 2020.
All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC.